Transmedics Group Inc
NASDAQ:TMDX

Watchlist Manager
Transmedics Group Inc Logo
Transmedics Group Inc
NASDAQ:TMDX
Watchlist
Price: 136.51 USD -1.53% Market Closed
Market Cap: 4.7B USD

Transmedics Group Inc
Retained Earnings

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Transmedics Group Inc
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Transmedics Group Inc
NASDAQ:TMDX
Retained Earnings
-$383.3m
CAGR 3-Years
7%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Retained Earnings
$4.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Retained Earnings
$49.1B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
7%
IDEXX Laboratories Inc
NASDAQ:IDXX
Retained Earnings
$6.1B
CAGR 3-Years
21%
CAGR 5-Years
25%
CAGR 10-Years
36%
Intuitive Surgical Inc
NASDAQ:ISRG
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Transmedics Group Inc
Glance View

TransMedics Group Inc. emerged as a pioneering force within the medical technology sphere, aiming to revolutionize the organ transplant landscape. Founded with the bold vision of enhancing the viability of donor organs, TransMedics has developed the Organ Care System (OCS) — a portable, medical device designed to keep human organs alive and functioning outside of the body. The OCS effectively mimics the internal conditions of a human body, providing a nurturing environment that maintains organs in a near-living state. This innovation helps extend the time that organs can be viably transplanted, thereby increasing the success rates of transplants and offering a lifeline to individuals on long waiting lists. Monetizing this groundbreaking technology, TransMedics operates primarily through sales of its OCS products and related consumables, catering to well-established transplant centers worldwide. The company also taps into service agreements and training packages, ensuring that their clients can maximize the use and benefits of their products with the highest proficiency. In doing so, TransMedics not only empowers surgeons and hospitals to perform more successful transplants but also strengthens its position as a leading provider in a niche yet critical market. By addressing the challenges of organ preservation and transportation, TransMedics creates a compelling business model rooted in providing invaluable solutions for the healthcare industry and, ultimately, improving patient outcomes on a global scale.

TMDX Intrinsic Value
HIDDEN
Show

See Also

What is Transmedics Group Inc's Retained Earnings?
Retained Earnings
-383.3m USD

Based on the financial report for Sep 30, 2025, Transmedics Group Inc's Retained Earnings amounts to -383.3m USD.

What is Transmedics Group Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
0%

Over the last year, the Retained Earnings growth was 19%. The average annual Retained Earnings growth rates for Transmedics Group Inc have been 7% over the past three years .

Back to Top